Clover Health Investments, Corp.
Clover Health Investments, Corp. (CLOV) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
clov · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Clover Health Investments, Corp. (CLOV) measures how much investors pay for each dollar of the company's trailing earnings. CLOV's current PE ratio of N/A is calculated by dividing its stock price of $3.91 by its TTM earnings per share of -$0.11.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2018 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Healthcare Plans · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Clover Health Investments, Corp.You CLOV | $2.0B | N/A | — | -$0.11 |
 BGM Group Ltd. BGM | $59M | N/A | — | -$0.20 |
 Certara, Inc. CERT | $814M | N/A | — | -$0.01 |
 Structure Therapeutics Inc. GPCR | $2.1B | N/A | — | -$2.39 |
 Guardian Pharmacy Services, Inc. GRDN | $2.6B | 38.14x | -66.1% | $0.79 |
 LifeStance Health Group, Inc. LFST | $2.9B | 281.23x | +150.3% | $0.03 |
 National HealthCare Corporation NHC | $3.0B | 17.67x | -84.3% | $7.76 |
Industry Average 3 peers with valid PE | — | 112.35x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.17 | — | |
2024-12-31 FY2024 | — | $-0.09 | — | |
2023-12-31 FY2023 | — | $-0.44 | — | |
2022-12-31 FY2022 | — | $-0.71 | — | |
2021-12-31 FY2021 | — | $-1.25 | — | |
2020-12-31 FY2020 | — | $-0.34 | — | |
2019-12-31 FY2019 | — | $-0.90 | — | |
2018-12-31 FY2018 | — | $-4.81 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Clover Health Investments, Corp. (CLOV) measures how much investors pay for each dollar of the company's trailing earnings. CLOV's current PE ratio of N/A is calculated by dividing its stock price of $3.91 by its TTM earnings per share of -$0.11.
Frequently asked questions
CLOV pe ratio · 6 questionsCLOV's current PE ratio is N/A as of 2026-06-08, based on a stock price of $3.91 and TTM EPS of -$0.11. Data sourced from Financial Modeling Prep via CLOV's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Clover Health Investments, Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08